Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-729,597
Closed -$73.4M 3241
2025
Q2
$73.4M Buy
+729,597
New +$55.8M 0.32% 35
2024
Q2
Sell
-24,944
Closed -$676K 2621
2024
Q1
$676K Sell
24,944
-81,791
-77% -$2.29M ﹤0.01% 1095
2023
Q4
$3.31M Buy
+106,735
New +$2.77M 0.02% 445
2023
Q3
Sell
-14,521
Closed -$306K 2726
2023
Q2
$306K Buy
+14,521
New +$276K ﹤0.01% 1615
2022
Q4
Sell
-33,945
Closed -$731K 2780
2022
Q3
$731K Sell
33,945
-19,066
-36% -$457K 0.01% 1204
2022
Q2
$1.04M Buy
53,011
+42,347
+397% +$887K 0.01% 887
2022
Q1
$250K Buy
+10,664
New +$248K ﹤0.01% 2360
2020
Q4
Sell
-38,036
Closed -$1.22M 2132
2020
Q3
$1.22M Buy
+38,036
New +$1.09M 0.04% 418
2020
Q1
Sell
-16,225
Closed -$387K 1036
2019
Q4
$387K Buy
+16,225
New +$330K 0.02% 636

Other funds holding INSM

HRT Financial's INSM Position: Q3 2025 in Review

HRT Financial sold out of Insmed (INSM) in Q3 2025, closing a stake of 729,597 shares — an estimated $73.4M sold.

HRT Financial first reported a position in INSM in Q4 2019 and held it in 9 quarters. The position peaked at $73.4M in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • HRT Financial reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 729,597 Insmed shares in Q3 2025, an estimated $73.4M.
  • HRT Financial first reported a position in Insmed in Q4 2019 and held it in 9 quarters.
  • HRT Financial's Insmed position peaked at $73.4M in Q2 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.